Cytosorbents Corporation (CTSO) vs Sanuwave Health Inc. (SNWV)
- Cytosorbents Corporation CTSO 5.26 −5.57%
- Sanuwave Health Inc. SNWV 1.64 −4.09%
Cytosorbents Corporation and Sanuwave Health Inc. are both Medical Devices companies. Cytosorbents Corporation is the larger, with a market value of $17.5M against $14.7M — 1.2× the size. Cytosorbents Corporation has negative trailing earnings, so its P/E is not meaningful; Sanuwave Health Inc. trades at 3.3×. Cytosorbents Corporation grew revenue faster over the last twelve months: 3.07% against 0.85%. Sanuwave Health Inc. has the higher net margin (10.1% vs −48.9%) and the higher return on invested capital (−2.11% vs −66.9%). Across the 17 metrics below, Sanuwave Health Inc. leads on 13 and Cytosorbents Corporation on 4.
Valuation
Profitability
| Metric | CTSO | SNWV | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.61% | 76.18% | 58.08% |
| Operating margin | (34.74%) | (1.14%) | (17.17%) |
| Net margin | (48.94%) | 10.05% | (16.35%) |
| Free cash flow margin | (25.32%) | 6.67% | (6.21%) |
| Return on equity | (336.17%) | (10,259.26%) | (21.47%) |
| Return on assets | (42.38%) | 12.20% | (17.83%) |
| Return on invested capital | (66.90%) | (2.11%) | (8.54%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack